Mapmygenome Acquires Canadian Firm Microbiome Insights to Expand Global Footprint

Acquisition strengthens expertise in microbiome research and accelerates entry into the North American market.

Hyderabad-based genomics and personalized health company Mapmygenome has announced the acquisition of Microbiome Insights, a Canadian company specializing in microbial sequencing. 

The deal includes 100% ownership of the company, along with its College of American Pathologists (CAP)-accredited laboratory and its intellectual property.

Although the financial terms of the acquisition were not disclosed, Mapmygenome's Founder and CEO, Anu Acharya, confirmed full ownership of the Vancouver-based company, which has been operating for over a decade.

Strategic Expansion & Scientific Strength

The acquisition is expected to enhance Mapmygenome's scientific capabilities in fields such as metagenomics, transcriptomics, and targeted metabolomics, allowing it to better serve academic, clinical, and biotechnology sectors globally. 

According to Acharya, the deal represents a key milestone in the company's strategic expansion into North America and aligns with its plan to go public in India later this year.

Established by experts including Dr. Brett Finlay, Dr. William Mohn, and Malcolm Kendall, Microbiome Insights has delivered over 1,000 microbiome studies for over 600 clients across various sectors, including pharma, biotech, nutrition, cosmetics, and agriculture.

Integrated Offerings & Future Outlook

Following the acquisition, Microbiome Insights will continue operating as a leading clinical research organization (CRO). 

Meanwhile, Mapmygenome will introduce integrated genomics and microbiome testing services across North America to promote holistic, data-driven healthcare.

"The human microbiome is pivotal to health. This acquisition positions us as a leader in the field," said Acharya. 

Microbiome Insights CEO Malcolm Kendall added that the deal will enable his company to deliver higher-quality services and drive future growth.

Stay tuned for more such updates on Digital Health News.

Stay tuned for more such updates on Digital Health News